Preoperative erythropoietin alpha reduces postoperative transfusions in THA and TKA but may not be cost-effective.
about
The effectiveness of a de-implementation strategy to reduce low-value blood management techniques in primary hip and knee arthroplasty: a pragmatic cluster-randomized controlled trialPerioperative blood management strategies for patients undergoing total knee replacement: Where do we stand now?What Are Risk Factors for 30-day Morbidity and Transfusion in Total Shoulder Arthroplasty? A Review of 1922 Cases.Cost benefit analysis of the use of tranexamic acid in primary lower limb arthroplasty: A retrospective cohort study.The effectiveness and safety of preoperative use of erythropoietin in patients scheduled for total hip or knee arthroplasty: A systematic review and meta-analysis of randomized controlled trials.Erythropoietin to reduce allogeneic red blood cell transfusion in patients undergoing total hip or knee arthroplasty.Relative efficacy of tranexamic acid and preoperative anemia treatment for reducing transfusions in total joint arthroplasty.Does Postoperative Erythropoietin Reduce Transfusions and Hemodynamic Instability Following Liposuction, Either Alone or Associated with Abdominoplasty or Mammaplasty? A Comparative, Prospective Study of 50 Consecutive Patients.Preoperative optimisation of anaemia for primary total hip arthroplasty: a systematic review.Factors that influence blood loss and need for transfusion following total knee arthroplasty.Ferric carboxymaltose with or without erythropoietin in anemic patients with hip fracture: a randomized clinical trial.
P2860
Q33742427-07409836-C235-4979-BC30-AEECBCA8C292Q33818396-5FD9C29D-DFAD-4473-AE70-E5106AA9D55CQ35567473-97FF136E-CB29-456E-A936-787640A99381Q36391392-398AEA1D-E88C-4A14-AA73-19DA7F2C4594Q37328116-ACBD8C14-AD52-4C51-A7D4-4B07E290D7E1Q38868207-51E0730A-25B2-42F6-B9F3-461FF7B02EB7Q39041949-3B53F9E8-D8CB-4890-BE06-00329895456FQ39048446-AC81589F-E7C7-4C01-8273-B7FF0B3FA6B4Q39366735-9E5EB121-5A2A-4FC2-97CD-8E7E5AAD74FEQ47224729-F6E0EB99-D40A-4BBE-9DF5-C55A26F96439Q47745978-9888A791-AA3A-4107-A61E-6CF80E239CD4
P2860
Preoperative erythropoietin alpha reduces postoperative transfusions in THA and TKA but may not be cost-effective.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Preoperative erythropoietin al ...... but may not be cost-effective.
@ast
Preoperative erythropoietin al ...... but may not be cost-effective.
@en
Preoperative erythropoietin al ...... but may not be cost-effective.
@nl
type
label
Preoperative erythropoietin al ...... but may not be cost-effective.
@ast
Preoperative erythropoietin al ...... but may not be cost-effective.
@en
Preoperative erythropoietin al ...... but may not be cost-effective.
@nl
prefLabel
Preoperative erythropoietin al ...... but may not be cost-effective.
@ast
Preoperative erythropoietin al ...... but may not be cost-effective.
@en
Preoperative erythropoietin al ...... but may not be cost-effective.
@nl
P2093
P2860
P1476
Preoperative erythropoietin al ...... but may not be cost-effective.
@en
P2093
Hany Bedair
Joseph C McCarthy
Maureen K Dwyer
P2860
P2888
P304
P356
10.1007/S11999-014-3819-Z
P407
P577
2015-02-01T00:00:00Z
P6179
1029145655